Analysts Anticipate Aetna (AET) Will Announce Quarterly Sales of $15.51 Billion

Equities research analysts expect that Aetna (NYSE:AET) will announce sales of $15.51 billion for the current fiscal quarter, Zacks reports. Six analysts have provided estimates for Aetna’s earnings, with estimates ranging from $15.18 billion to $15.92 billion. Aetna reported sales of $15.50 billion during the same quarter last year, which indicates a positive year-over-year growth rate of 0.1%. The firm is expected to issue its next quarterly earnings results on Thursday, August 2nd.

On average, analysts expect that Aetna will report full year sales of $61.41 billion for the current fiscal year, with estimates ranging from $59.49 billion to $63.44 billion. For the next fiscal year, analysts expect that the business will post sales of $64.83 billion per share, with estimates ranging from $61.51 billion to $67.69 billion. Zacks’ sales calculations are a mean average based on a survey of analysts that that provide coverage for Aetna.

Aetna (NYSE:AET) last released its earnings results on Tuesday, May 1st. The company reported $3.19 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.97 by $0.22. The firm had revenue of $15.34 billion for the quarter, compared to analysts’ expectations of $15.32 billion. Aetna had a return on equity of 21.42% and a net margin of 5.76%. The business’s quarterly revenue was up 1.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.71 EPS.



A number of equities research analysts have recently issued reports on AET shares. Jefferies Group reiterated a “hold” rating and set a $205.00 price objective on shares of Aetna in a research note on Wednesday, January 31st. Deutsche Bank upgraded Aetna from a “hold” rating to a “buy” rating and upped their price objective for the stock from $195.00 to $212.00 in a research note on Monday, January 22nd. Citigroup cut Aetna from a “buy” rating to a “neutral” rating and upped their price objective for the stock from $187.89 to $212.00 in a research note on Wednesday, January 31st. Cowen reiterated a “buy” rating and set a $212.00 price objective on shares of Aetna in a research note on Tuesday, January 30th. Finally, Credit Suisse Group upped their price objective on Aetna from $200.00 to $208.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 31st. Eight equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $196.36.

Aetna traded down $0.22, hitting $176.81, during trading on Thursday, according to Marketbeat.com. The stock had a trading volume of 1,559,684 shares, compared to its average volume of 2,059,260. The stock has a market capitalization of $57.83 billion, a price-to-earnings ratio of 17.93, a PEG ratio of 1.49 and a beta of 0.64. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.73 and a current ratio of 0.73. Aetna has a 12 month low of $139.45 and a 12 month high of $194.40.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 1st. Shareholders of record on Wednesday, July 25th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.13%. Aetna’s dividend payout ratio is 20.28%.

Hedge funds and other institutional investors have recently modified their holdings of the business. Pennsylvania Trust Co bought a new stake in shares of Aetna during the 4th quarter valued at $200,000. Davis R M Inc. bought a new stake in shares of Aetna during the 4th quarter valued at $218,000. Bank of Montreal Can lifted its position in shares of Aetna by 67.2% during the 4th quarter. Bank of Montreal Can now owns 462,914 shares of the company’s stock valued at $83,504,000 after acquiring an additional 186,033 shares during the period. City Holding Co. lifted its position in shares of Aetna by 23.8% during the 4th quarter. City Holding Co. now owns 2,760 shares of the company’s stock valued at $498,000 after acquiring an additional 530 shares during the period. Finally, CHICAGO TRUST Co NA lifted its position in shares of Aetna by 6.0% during the 4th quarter. CHICAGO TRUST Co NA now owns 16,726 shares of the company’s stock valued at $3,018,000 after acquiring an additional 949 shares during the period. 87.01% of the stock is currently owned by hedge funds and other institutional investors.

Aetna Company Profile

Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.

Get a free copy of the Zacks research report on Aetna (AET)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply